Document Classification

Section Type: RESULTS

Text: The estimated 28-week risk of HIV-1 transmission was 5. 8 % (95 % confidence interval [CI], 4. 3 % -7. 9 %) for the 6-week nevirapine regimen, 3. 7 % (95 % CI, 2. 5 % -5. 4 %) for the 14-week nevirapine regimen, 4. 8 % (95 % CI, 3. 5 % -6. 7 %) for the 14-week nevirapine plus zidovudine regimen, and 1. 8 % (95 % CI, 1. 0 % -3. 1 %) for the 28-week nevirapine regimen (log-rank test for trend, P <. 001).